Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Preclinical Imaging in Targeted Cancer Therapies.

Iommelli F, De Rosa V, Terlizzi C, Fonti R, Del Vecchio S.

Semin Nucl Med. 2019 Sep;49(5):369-381. doi: 10.1053/j.semnuclmed.2019.06.003. Epub 2019 Jun 19. Review.

PMID:
31470932
2.

Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells.

De Rosa V, Monti M, Terlizzi C, Fonti R, Del Vecchio S, Iommelli F.

Int J Mol Sci. 2019 Jun 27;20(13). pii: E3134. doi: 10.3390/ijms20133134.

3.

Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins.

Monti M, De Rosa V, Iommelli F, Carriero MV, Terlizzi C, Camerlingo R, Belli S, Fonti R, Di Minno G, Del Vecchio S.

Int J Mol Sci. 2018 Aug 9;19(8). pii: E2350. doi: 10.3390/ijms19082350.

4.

Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by 18F-fluorothymidine.

Iommelli F, De Rosa V, Terlizzi C, Monti M, Panico M, Fonti R, Del Vecchio S.

Clin Cancer Res. 2018 Jul 1;24(13):3126-3136. doi: 10.1158/1078-0432.CCR-17-3657. Epub 2018 Apr 4.

5.

Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells.

Monti M, Iommelli F, De Rosa V, Carriero MV, Miceli R, Camerlingo R, Di Minno G, Del Vecchio S.

PLoS One. 2017 Feb 6;12(2):e0171362. doi: 10.1371/journal.pone.0171362. eCollection 2017.

6.

Preclinical imaging in oncology: advances and perspectives.

Iommelli F, DE Rosa V, Terlizzi C, Del Vecchio S.

Q J Nucl Med Mol Imaging. 2017 Mar;61(1):33-47. doi: 10.23736/S1824-4785.16.02949-6. Epub 2016 Nov 18. Review.

7.
8.

Combination of Aβ Secretion and Oxidative Stress in an Alzheimer-Like Cell Line Leads to the Over-Expression of the Nucleotide Excision Repair Proteins DDB2 and XPC.

Forestier A, Douki T, De Rosa V, Béal D, Rachidi W.

Int J Mol Sci. 2015 Jul 30;16(8):17422-44. doi: 10.3390/ijms160817422.

9.

Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer.

De Rosa V, Iommelli F, Monti M, Fonti R, Votta G, Stoppelli MP, Del Vecchio S.

Clin Cancer Res. 2015 Nov 15;21(22):5110-20. doi: 10.1158/1078-0432.CCR-15-0375. Epub 2015 Jul 27.

10.

Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography.

Iommelli F, De Rosa V, Gargiulo S, Panico M, Monti M, Greco A, Gramanzini M, Ortosecco G, Fonti R, Brunetti A, Del Vecchio S.

Clin Cancer Res. 2014 Sep 15;20(18):4806-15. doi: 10.1158/1078-0432.CCR-14-0264. Epub 2014 Jul 22.

11.

Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention?

Bera S, De Rosa V, Rachidi W, Diamond AM.

Mutagenesis. 2013 Mar;28(2):127-34. doi: 10.1093/mutage/ges064. Epub 2012 Nov 30. Review.

12.

Alzheimer's disease-associated neurotoxic peptide amyloid-β impairs base excision repair in human neuroblastoma cells.

Forestier A, Douki T, Sauvaigo S, De Rosa V, Demeilliers C, Rachidi W.

Int J Mol Sci. 2012 Nov 13;13(11):14766-87. doi: 10.3390/ijms131114766.

13.

Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells.

de Rosa V, Erkekoğlu P, Forestier A, Favier A, Hincal F, Diamond AM, Douki T, Rachidi W.

Free Radic Res. 2012 Feb;46(2):105-16. doi: 10.3109/10715762.2011.647009. Epub 2012 Jan 25.

14.

Protective effect of selenium supplementation on the genotoxicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate treatment in LNCaP cells.

Erkekoğlu P, Rachidi W, De Rosa V, Giray B, Favier A, Hincal F.

Free Radic Biol Med. 2010 Aug 15;49(4):559-66. doi: 10.1016/j.freeradbiomed.2010.04.038. Epub 2010 May 11.

PMID:
20466057

Supplemental Content

Loading ...
Support Center